Key points from article :
Pixium Vision has received approval in France to start a clinical trial.
PRIMA is a miniature wireless sub-retinal implant.
Will be implanted into 5 patients with vision loss due to advanced dry age-related macular degeneration (dry-AMD).
PRIMA electrodes can detect infrared signals and transform them into electrical impulses to be transmitted through the optic nerve.
4 million people suffer from AMD with no treatment options available.
